CJC-1295 & Ipamorelin Blend (10mg) Research Peptide: A Dual‑Pathway Synergistic Tool for Growth Hormone Studies

If your research explores the hypothalamic-pituitary-somatotropic axis, the dynamics of growth hormone (GH) secretion, or the physiological effects of pulsatile GH release, the CJC-1295 & Ipamorelin Blend (10mg) research peptide offers a precisely defined, dual‑pathway experimental platform. This 10 mg formulation combines two mechanistically distinct yet complementary GH secretagogues—CJC-1295 (Mod GRF 1‑29), a modified GHRH analogue, and Ipamorelin, a selective ghrelin receptor agonist.

By simultaneously targeting the GHRH receptor and the growth hormone secretagogue receptor (GHS‑R1a), this blend allows researchers to model the synergistic interplay between GHRH and ghrelin pathways, providing deeper insight into the regulatory circuits that govern GH pulsatility and IGF‑1 signalling. Research demonstrates that co‑administration of GHRH with growth hormone‑releasing peptides produces GH peaks far exceeding those achieved by either agent alone—a true synergistic effect arising from convergent activation of two independent intracellular signalling cascades on the same somatotroph cell.

This makes the CJC-1295 & Ipamorelin Blend (10mg) research peptide a valuable tool for laboratories investigating GH regulation, metabolic research, and the complex interplay between GHRH and ghrelin signalling pathways.

At Chinese Grey Peptides, we supply high‑purity CJC-1295 & Ipamorelin Blend (10mg) research peptide to research institutions and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is lyophilised, HPLC‑verified to ≥99% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into GH regulation, IGF‑1 signalling, and metabolic research begin with uncompromising quality.

What Is the CJC‑1295 & Ipamorelin Blend and How Does It Work?

To fully appreciate the research potential of the CJC-1295 & Ipamorelin Blend (10mg) research peptide, it is essential to understand the distinct yet complementary mechanisms of its two components. Each peptide exploits a separate G‑protein‑coupled receptor (GPCR) with divergent downstream signalling, yet both ultimately converge on the somatotroph’s secretory machinery. The blend is among the most widely discussed GH peptide combinations in the research community, often sold as a pre‑blended 10 mg vial (5 mg CJC‑1295 + 5 mg Ipamorelin) at a 1:1 ratio.

CJC-1295 (Mod GRF 1-29): The GHRH Receptor Agonist

CJC‑1295 is a synthetic peptide derivative of growth hormone‑releasing hormone (GHRH), specifically a tetrasubstituted analogue of the N‑terminal 29 amino acids of hGRF(1‑29). Unlike CJC‑1295‑DAC, which contains a drug affinity complex (DAC) moiety and has an extended half‑life of approximately 6‑8 days, the version in this blend—CJC‑1295 without DAC (also called Modified GRF 1‑29)—does not contain the DAC moiety.

It features four specific amino acid substitutions that confer resistance to enzymatic degradation and enhance bioactivity. The absence of the DAC moiety is a deliberate design feature: CJC‑1295 without DAC has a biological half‑life of approximately 30 minutes and supports a more physiological pulsatile release pattern that closely mimics the body’s natural GH rhythm. CJC‑1295 has been the subject of 28 peer‑reviewed publications indexed in PubMed.

Ipamorelin: The Selective Ghrelin Receptor Agonist

Ipamorelin is a synthetic pentapeptide first characterised by Raun et al. (1998) as a highly selective GHS‑R1a agonist. It was developed specifically to release GH without the confounding effects of earlier GHRPs—no significant elevation of ACTH, cortisol, prolactin, FSH, or TSH—making it the cleanest experimental tool for isolating GH‑pulse pharmacology. Ipamorelin engages the GHS‑R1a receptor coupled to Gq/11, triggering phospholipase C, inositol trisphosphate production, and intracellular calcium mobilization.

Mechanism of Synergy: Dual‑Receptor Activation

The scientific rationale for combining CJC‑1295 and Ipamorelin lies in their convergent yet distinct mechanisms. The two compounds hit completely different receptor systems on the same pituitary cells:

• CJC‑1295 binds the GHRH receptor (GHRH‑R), a class B GPCR on somatotrophs, activating adenylyl cyclase through Gs‑alpha coupling. This increases intracellular cAMP and activates protein kinase A (PKA), which drives GH gene transcription, GH protein synthesis, and priming of secretory vesicles for release. CJC‑1295 sets the amplitude baseline—it determines how much GH is available to be released.

• Ipamorelin activates GHS‑R1a, a class A GPCR that couples through Gq/11, triggering phospholipase C, inositol trisphosphate (IP3), and diacylglycerol (DAG), which mobilise intracellular calcium and activate protein kinase C (PKC). The calcium surge triggers immediate exocytosis of the GH vesicles that CJC‑1295 helped synthesise and prime.

• Synergistic Convergence: The two pathways converge on GH exocytosis with more than additive effect—CJC‑1295 fills the gun (GH synthesis and vesicle loading), while Ipamorelin pulls the trigger (calcium‑mediated exocytosis). Co‑activation produces a GH pulse substantially greater than the sum of individual responses, as demonstrated by Bowers et al. (1990). Additionally, ghrelin receptor activation antagonises somatostatin signalling at the hypothalamic level, reducing the inhibitory tone that would otherwise limit GHRH‑driven GH release.

Research Note: The Physiological Advantage

Growth hormone release from the pituitary is naturally pulsatile—roughly 5–7 peaks per 24 hours, with the largest occurring during slow‑wave sleep. This pulsatility matters: continuous GH exposure produces different hepatic gene expression patterns than pulsatile exposure. The CJC‑1295 + Ipamorelin combination has become a standard research tool because it drives stronger GH pulses than either compound alone—through two mechanistically distinct receptor pathways working together. The short half‑lives (~30 min for CJC‑1295, ~2 hours for Ipamorelin) create a discrete GH pulse that rises and falls within 2‑3 hours, mimicking endogenous GH secretory episodes.

Key Research Applications for the CJC-1295 & Ipamorelin Blend (10mg)

The CJC-1295 & Ipamorelin Blend (10mg) research peptide is a versatile tool with applications spanning several domains of biomedical research.

1. Growth Hormone Axis & Pituitary Function Studies

This blend provides a powerful model for investigating the hypothalamic‑pituitary‑somatotropic axis. Researchers can use it to study:

• The synergistic effects of GHRH and ghrelin pathway co‑activation on GH synthesis, storage, and pulsatile release

• The distinct contributions of GHRH‑mediated and ghrelin‑mediated signalling to overall GH secretion

• The dynamics of GH pulse amplitude and frequency in response to dual‑pathway stimulation

• Receptor cross‑talk and bias between GHRHR and GHS‑R1a

2. Metabolic & Body Composition Research

By stimulating endogenous GH release through two pathways, this blend provides a model for studying the downstream metabolic effects of GH and IGF‑1 elevation. Research applications include:

• Body Composition Studies: In diet‑induced obese (DIO) and aged rodent models, measuring lean/fat mass shifts

• Lipid Metabolism: Exploring the role of GH in lipolysis and fat oxidation pathways

• Glucose Homeostasis: Investigating how GH modulation impacts glucose regulation and insulin sensitivity

• Tachyphylaxis Studies: Receptor desensitisation kinetics with repeated administration

3. IGF‑1 Signalling & Hepatic Research

Research suggests that pulsatile GH exposure produces measurable consequences for IGF‑1 generation. Growth hormone secretagogues like ipamorelin and CJC‑1295 activate IGF‑1 signalling and satellite cell repair. Research applications include:

• IGF‑1 Generation Studies: Investigating downstream hepatic responses to sustained versus pulsatile GH

• Synergistic Amplification: Characterising the supraadditive calcium mobilisation and GH vesicle exocytosis

4. Sleep & Recovery Research

The CJC‑1295 + Ipamorelin stack is commonly associated with post‑exercise recovery research, sleep‑quality research, and the physiological relationship between GH pulse contribution and slow‑wave sleep physiology.

5. Comparative GHS Pharmacology Research

This blend provides a valuable comparator for studying different GH secretagogues, including:

• Comparison against Sermorelin, MK‑677, and older GHRP secretagogues

• Investigating the clean selectivity profile of Ipamorelin versus GHRP‑6 and GHRP‑2

• Characterising the distinct signalling pathways activated by Gs‑coupled (GHRH) versus Gq/11‑coupled (GHS‑R1a) receptors

Chemical & Physical Specifications for CJC-1295 & Ipamorelin Blend (10mg)

Accurate characterisation of the CJC-1295 & Ipamorelin Blend (10mg) research peptide is essential for reproducible experimental design.

Note: The 10 mg mass represents the total peptide weight of the blend (5 mg CJC‑1295 (Mod GRF 1‑29) + 5 mg Ipamorelin). The blend is supplied in a single lyophilised vial. CJC‑1295 in this blend does not contain the Drug Affinity Complex (DAC) moiety, preserving physiological pulsatility. This product is intended strictly for in‑vitro and laboratory research use only (RUO). Not for human or animal use.

Reconstitution & Handling Protocol for the CJC‑1295 & Ipamorelin Blend (10mg)

Proper reconstitution of the CJC-1295 & Ipamorelin Blend (10mg) research peptide is critical for maintaining the structural integrity and biological activity of both peptides.

Step 1 – Preparation

• Bring the sealed blend vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH 5‑7) to room temperature. Condensation can degrade the lyophilised powder.

• Clean your work surface with 70% ethanol and lay out sterile syringes, alcohol wipes and a clean work mat.

Step 2 – Vial Sanitisation

• Wipe the rubber stopper of the blend vial with a fresh 70% ethanol wipe. Allow the alcohol to evaporate completely before piercing.

Step 3 – Reconstitution

• Draw your desired volume of diluent into a sterile syringe. A common starting concentration for research applications is 10 mg per 1 mL of diluent, yielding a 10 mg/mL total peptide concentration (5 mg/mL of each component).

• Insert the needle and slowly inject the diluent against the inner glass wall. Do not spray directly onto the lyophilised powder.

• Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously, as shaking can cause denaturation.

Step 4 – Aliquoting & Storage

• Immediately after dissolution, aliquot the reconstituted peptide blend into single‑use sterile vials.

• Store aliquots at –20°C. Avoid repeated freeze‑thaw cycles, as peptides are susceptible to degradation.

• Once thawed, store at 2‑8°C and use within 4 weeks.

Concentration Reference Table for CJC-1295 & Ipamorelin Blend (10mg)

Adjust diluent volume based on your experimental requirements. The exact concentration of each individual peptide within the blend is 5 mg CJC‑1295 (Mod GRF 1‑29) and 5 mg Ipamorelin per 10 mg vial.

Storage & Stability Guidelines for CJC-1295 & Ipamorelin Blend (10mg)

Why Choose Chinese Grey Peptides for the CJC-1295 & Ipamorelin Blend (10mg)?

As an authentic licensed peptide supplier based in the USA, we supply the CJC-1295 & Ipamorelin Blend (10mg) research peptide and a wide range of research‑grade compounds under rigorous quality assurance protocols, fully aligned with Google’s E‑E‑A‑T standards (Experience, Expertise, Authoritativeness, Trustworthiness).

• Verified Purity: Independent HPLC analysis with purity guaranteed ≥99% for each component, every batch.

• GMP‑Compliant Manufacturing: All peptides are synthesised under strict quality control conditions.

• Full Traceability: Batch‑specific Certificates of Analysis (COA) are available for every order.

• Wholesale Supply: We serve research institutions, laboratories, and wholesale buyers across the UK, EU, and USA with flexible volume pricing and reliable logistics.

• USA‑Based Regulatory Compliance: All products are supplied strictly as research‑grade chemicals for laboratory use only (RUO). This peptide blend is intended strictly for laboratory research, analytical, or reference use, where permitted by local regulations. Not for human or veterinary use.

Researchers across the United States—including those at leading institutions—trust us for fast domestic delivery, transparent documentation and professional technical support.

FAQ: CJC-1295 & Ipamorelin Blend (10mg) Research Peptide

What is the CJC-1295 & Ipamorelin Blend (10mg) research peptide?
It is a research‑grade formulation combining CJC‑1295 (Mod GRF 1‑29, a modified GHRH analogue without DAC) and Ipamorelin (a selective ghrelin receptor agonist). It is the most widely discussed GH peptide combination in the research community, often sold as a pre‑blended 10 mg vial (5 mg CJC‑1295 + 5 mg Ipamorelin) at a 1:1 ratio.

How does each component work?
CJC‑1295 (Mod GRF 1‑29) binds to GHRH receptors on pituitary somatotrophs via Gs‑coupled signalling, stimulating GH synthesis and release through the cAMP/PKA pathway. Ipamorelin binds to the growth hormone secretagogue receptor (GHS‑R1a) via Gq/11‑coupled signalling, triggering phospholipase C and intracellular calcium mobilization to drive GH exocytosis.

 What is the proposed synergy between CJC‑1295 and Ipamorelin?
CJC‑1295 fills the gun (GH synthesis and vesicle loading), while Ipamorelin pulls the trigger (calcium‑mediated exocytosis). Co‑activation produces a GH pulse substantially greater than the sum of individual responses, as demonstrated by Bowers et al. (1990).

 What makes Ipamorelin the preferred GHRP partner in this blend?
Ipamorelin was engineered for GH selectivity—it produces GH release comparable to GHRP‑6 but with minimal prolactin and cortisol stimulation, making it the cleanest experimental tool for isolating GH‑pulse pharmacology.

What is the difference between CJC‑1295 with DAC and without DAC?
CJC‑1295 without DAC (Mod GRF 1‑29) has a half‑life of approximately 30 minutes and supports a pulsatile release pattern that closely mimics natural physiology. CJC‑1295 with DAC has a half‑life of approximately 6‑8 days and produces sustained, continuous GH elevation.

 What purity does your CJC‑1295 & Ipamorelin Blend (10mg) meet?
Each component is tested to ≥99% purity by HPLC. A Certificate of Analysis (COA) is supplied with every order.

 How should I reconstitute this peptide blend?
Reconstitute with sterile bacteriostatic water or sterile PBS (pH 5‑7). Allow the vial to reach room temperature, then slowly inject the diluent against the inner glass wall and swirl gently. Do not shake. A typical starting concentration is 10 mg/mL.

 How should I store reconstituted peptide blends?
Reconstituted blends should be stored at 2‑8°C and used within 4 weeks. For longer storage, aliquot immediately into single‑use vials and store at –20°C for up to 3 months. Avoid repeated freeze‑thaw cycles.

 Is this peptide blend legal to purchase in the USA for research?
Yes. This blend is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the United States for legitimate in‑vitro or in‑vivo scientific research, provided it is not marketed with therapeutic https://chinesegreypeptides.com/bulk-orders/claims. Note: CJC‑1295 and Ipamorelin are not FDA‑approved for therapeutic use and are prohibited by the World Anti‑Doping Agency (WADA) for athletic use.

 Does Chinese Grey Peptides ship internationally?
Yes. We ship across the UK, Europe (France, Germany, Spain, Sweden, Italy), and the USA from our US warehouse. Wholesale pricing is available for bulk orders.

CJC-1295 & Ipamorelin Blend (10mg)

1. Shop Page
2. Bulk Orders Page
3. Contact Page
4. Shipping & Return Page
5. Peptide Purity Page

• PubChem CJC-1295
• PubChem Ipamorelin
• FDA compounding-risk page for CJC-1295
• FDA Gram Peptides warning letter
• WADA 2026 Prohibited List page
• Google Product Structured Data
• Rank Math WooCommerce Product Schema

CJC-1295 & Ipamorelin Blend (10mg)

Ships to USA, Canada, UK & Europe

Chinese Grey Peptides supports shipping to the USA, Canada, the United Kingdom, France, Germany, Spain, Sweden, Italy, and Europe where permitted.

Shipping support may include:

• Order processing updates
• Packaging support
• Tracking information where available
• Wholesale shipment planning
• Destination-based shipping review
• Customer support during transit

Shipping times may vary by order size, carrier, destination, customs process, product status, and local requirements.

Why Choose Chinese Grey Peptides?

Chinese Grey Peptides focuses on quality, support, and clear communication. We help buyers review product details before placing an order.

Customers choose us for:

• Professional peptide supplier support
• Small and wholesale order options
• Product documentation support
• HPLC testing information where available
• Mass Spectrum documentation where available
• International shipping support
• Responsive communication
• Clear order assistance before payment

We aim to make the buying process transparent, professional, and documentation-focused.

CJC-1295 & Ipamorelin Blend (10mg)

Important Compliance Notice

CJC-1295 Ipamorelin Blend 10mg may be regulated differently depending on the country, product type, labeling, intended use, buyer type, and destination. Chinese Grey Peptides does not provide medical advice, dosing instructions, injection guidance, growth hormone claims, anti-aging claims, fat-loss claims, muscle-growth claims, recovery claims, athletic-performance claims, bodybuilding claims, disease claims, treatment claims, or personal-use recommendations.

Customers are responsible for understanding and following all local laws, import rules, prescription requirements, compounding rules, sport-governing rules, labeling rules, and permitted-use requirements before ordering.

From its innovative design as a dual‑pathway GH secretagogue blend to its well‑documented role in modelling the synergistic interplay between the GHRH and ghrelin systems, the CJC‑1295 & Ipamorelin Blend (10mg) research peptide provides a uniquely versatile platform for advanced endocrinological and metabolic research.

CJC-1295 & Ipamorelin Blend (10mg)

Its ability to stimulate endogenous GH release through two distinct yet convergent pathways—CJC‑1295 providing GHRH‑receptor engagement via cAMP/PKA signalling and Ipamorelin amplifying through the ghrelin receptor axis via Gq/11 signalling—supported by research demonstrating synergistic GH release substantially greater than the sum of individual effects, makes it a valuable addition to any laboratory investigating the GH/IGF‑1 axis, metabolic regulation, or pulsatile endocrine signalling.

By choosing high‑purity, lab‑verified CJC-1295 & Ipamorelin Blend (10mg) research peptide from Chinese Grey Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.

Ready to advance your research with the CJC-1295 & Ipamorelin Blend (10mg)? Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory’s specific needs. Place your order now and receive GMP‑grade research peptides delivered directly to your facility in the USA, UK, or Europe.CJC-1295 & Ipamorelin Blend (10mg)

CJC-1295 & Ipamorelin Blend (10mg),CJC-1295 & Ipamorelin Blend (10mg),CJC-1295 & Ipamorelin Blend (10mg),CJC-1295 & Ipamorelin Blend (10mg)